Lumira Ventures
Lumira Ventures
Type of Funding
Venture Capital
Max Funding
N/A
Region
Federal/National
Application Difficuty
Fairly simple
Processing Time
Slow (A few months)
Province
All Of Canada
Industry
Health and other services.
Funding Goals
Start-up Funding.
Demographic
N/A
Incorporated
No
Contact
416.213.4223
Apply For A Loan
Business location – Canada
Monthly Revenue – $10K +
Time in Business – 6 months +
Funds in 24 hours
$10,000 to $800,000
Details
Built on a foundation that leverages over 20 years of experience as one of North America’s leading healthcare and life science venture capital investors, Lumira Ventures is the successor business to MDS Capital.
Their team is strategically situated across North America to identify innovative companies within and outside the traditional start-up hubs, and help them access capital, talent and strategic partners.
Eligibility
Mix of early, clinical and revenue stage companies that are both privately held and publically traded
Similar funding programs
Venture Capital
Whitecap Venture Partners is an early stage venture capital fund investing in high growth companies across three verticals: Information Communications Technology (ICT), Food Technology, Medical Technology
The Whitecap Venture Partners team is a group of former operators and investors who have invested together for over 30 years.
Max Funding N/A
Whitecap
Venture Capital
Durham's Neighbourhood Association of Angel Investors is the Government of Canada’s official angel group for the Durham Region. We are a group of community minded individuals, from all walks of life and backgrounds, that reflect the diverse make up and multi-cultural richness that represents the population in our region. Our focus is to enable high-potential entrepreneurs, with innovative, scalable ideas get the investment they need (a hand-up, not hand-out) so they can pursue their passions and entrepreneurial dreams right here in Durham.
Max Funding $400,000.00
Spark Angel
Venture Capital
Based in Montréal, CTI Life Sciences, a Canadian venture firm makes venture capital investments in high quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and in the U.S.
CTI Life Sciences currently manage $245 million of assets.
Max Funding N/A
CTI Life Sciences